Moderna's new vaccine targeting both SARS-CoV-2 and influenza is more effective in adults over 50 than separate flu and COVID-19 shots.
The use of RNA in combination vaccines like Moderna's showcases the technology's potential in overcoming development challenges.
[
Collection
]
[
|
...
]